Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Acq. announced
Appointed director
Quarterly results
CC transcript
GENZYME CORP (GENZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/08/2011 8-K Quarterly results
03/30/2011 8-K Other Events, Financial Statements and Exhibits
02/18/2011 8-K/A Form 8-K - Current report [amend]
02/16/2011 8-K Asset disposition
Docs: "Agreement and Plan of Merger, by and among Genzyme Corporation, Sanofi-Aventis, and GC Merger Corp. Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrants will furnish copies of any such schedules to the U.S. Securities and Exchange Commission upon request",
"Form of Contingent Value Rights Agreement, to be entered into by and among Sanofi-Aventis and Trustee",
"Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year Recovery Continues with Growth Across All Businesses",
"Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right"
02/01/2011 8-K Form 8-K - Current report
01/11/2011 8-K Form 8-K - Current report
11/05/2010 8-K Cost Associated with Exit or Disposal Activities
10/20/2010 8-K Form 8-K - Current report
09/13/2010 8-K Form 8-K - Current report
08/30/2010 8-K Form 8-K - Current report
07/21/2010 8-K Form 8-K - Current report
07/07/2010 8-K Entry into a Material Definitive Agreement
06/29/2010 8-K Regulation FD Disclosure
06/23/2010 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
06/22/2010 8-K Appointed a new director
Docs: "Restated Articles of Organization of Genzyme Corporation, as amended",
"Bylaws of Genzyme Corporation, as amended"
06/17/2010 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "EX-4.1(A)",
"EX-4.1(B)",
"Registration Rights Agreement, by and among Genzyme Corporation, Credit Suisse Securities (USA) LLC, Goldman, Sachs & Co. and Banc of America Securities LLC"
06/15/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Genzyme Prices Private Senior Notes Offerings Proceeds Will Support Stock Repurchase Plan"
06/09/2010 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement by and among Genzyme Corporation, Icahn Partners LP, Icahn Partners Master Fund LP, Icahn Partners Master Fund II L.P., Icahn Partners Master Fund III L.P. and High River Limited Partnership",
"Genzyme and Carl Icahn Reach Agreement",
"Dennis Fenton Nominated for Election to Genzyme's Board of Directors 25-Year Amgen Veteran Helped Build World-Class Biologics Manufacturing Operations"
05/24/2010 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Consent decree between Genzyme Corporation and the United States Food and Drug Administration"
04/21/2010 8-K Form 8-K - Current report
04/15/2010 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Amended and restated agreement between Genzyme Corporation, Relational Investors LLC, Ralph V. Whitworth and the other parties identified in the agreement",
"Ralph Whitworth Elected to Genzyme's Board of Directors"
04/08/2010 8-K Form 8-K - Current report
03/30/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Genzyme Creates Chief Operating Officer Position Appoints Executive Vice President David Meeker to New Role"
03/24/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Genzyme Announces FDA Enforcement Action Regarding Allston Plant Company Will Hold Conference Call Today at 11:00 a.m. Eastern"
02/22/2010 8-K Form 8-K - Current report
02/17/2010 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Genzyme Reports Financial Results for Fourth Quarter of 2009 and Full Year Confirms Outlook for Growth in 2010 Provides Supply Updates for Cerezyme and Fabrazyme"
01/28/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/12/2010 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Genzyme Reports Fourth-Quarter Revenue Outlines Progress Made in 2009 and Outlook for 2010"
01/07/2010 8-K Form 8-K - Current report
01/04/2010 8-K Entry into a Material Definitive Agreement
12/14/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/10/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "Letter to Genzyme Corporation Shareholders"
10/21/2009 8-K Form 8-K - Current report
10/15/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy